[Purpose] The aim of this study was to determine the functional differences between total
knee arthroplasty (TKA) patients who were treated with supervised physiotherapy or a
standardized home program and perform a cost analysis. [Subjects and Methods] Patients who
received total knee arthroplasty between January 2009 and June 2011 were enrolled in this
study; those with mean ages of 64.25±3.86 (60–68) years (n=18) and 68.08±6.25 (61–79)
years (n=16) were placed in the supervised physiotherapy and standardized home program
groups, respectively. All patients were evaluated by the same researcher before and after
surgery, and the therapy programs were applied by another physiotherapist. All patients
were evaluated for joint range of motion (ROM), pain, functional status (WOMAC), overall
quality of life (SF-36), and depressive symptoms (BECK Depression Scale). [Results] A
significant clinical improvement was observed in postoperative assessments. A
statistically significant difference could not be found between ROM and functional levels
of the patients in both groups. [Conclusion] No difference was found between the patients
performing supervised or standardized home program with respect to the effects on
functional status. A home exercise program can be used in the rehabilitation of patients
with TKA, and implementation of home exercise programs can also reduce health-care
spending.
The present study was planned to translate and culturally adapt the Olerud-Molander Ankle Score (OMAS) and assess the validity and reliability of the Turkish translation of the OMAS in patients with surgically treated malleolar fracture. The OMAS was adapted for use in Turkish by first translating it and then back-translating it in accordance with published guidelines. The final Turkish version of the OMAS was administered to 91 patients participating in the present study. The OMAS questionnaire was repeated 7 days later to assess test-retest reliability. Spearman's rank correlation analysis was used for each question's score and the total score, and the intraclass correlation coefficient was calculated for test-retest reliability. The internal consistency of the OMAS-TR was assessed using Cronbach's α. Concurrent validity was evaluated by comparing the OMAS with the Foot and Ankle Outcome Score and global self-rating function (GSRF). The GSRF has 5 options: very good, good, fair, poor, and very poor. These are assessed using a 5-point Likert scale. Before validity analysis, the GSRF score was reduced to 3 groups. In the test-retest reliability assessment, the OMAS showed high correlation (r = 0.882). The intraclass correlation coefficient was 0.942. Cronbach's α was 0.762 and 0.731 at days 1 and 7 (adequate internal consistency). The correlation coefficients versus the 5 subscales of the Foot and Ankle Outcome Score ranged from r = 0.753 to r = 0.809 (p = .000) and versus the GSRF was r = -0.794 (p = .000). According to results of the present study, the Turkish version of the OMAS demonstrated adequate test-retest reliability, excellent internal consistency, and evidence of validity for Turkish-speaking patients treated surgically for ankle fracture.
According to these results, mean fall risk of patients with ACL insufficiency was within high risk category preoperatively, and fall risk improves after surgical reconstruction, but as the duration of complaints lengthens especially longer than 6 months, the improvement of fall risk decreases following reconstruction.
Sacroiliac blockade has a similar therapeutic effect on patients who underwent lumbosacral fusion surgery as on non-operated patients in the middle-term. Therefore, alternative treatment options are not necessary in patients with fusion.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.